Putu Oky Ari Tania
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Putu Oky Ari Tania has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Afaf Baktir
Department of Chemistry, Faculty of Science and Technology, Airlangga University, Surabaya, Indonesia
1 shared publication Dorta Simamora
Bagian Biomedik Penelitian Biomolekuler Fakultas Kedokteran Universitas Wijaya Kusuma Surabaya
1 shared publicationFebtarini Rahmawati
Bagian Patologi Klinik Fakultas Kedokteran Universitas Wijaya Kusuma Surabaya
1 shared publication- Harsono Wiradinata
Department of Biochemistry, Faculty of Medicine, University of Wijaya Kusuma Surabaya, Surabaya, Indonesia
1 shared publication - Loo Hariyanto Raharjo
Department of Biochemistry, Faculty of Medicine, University of Wijaya Kusuma Surabaya, Surabaya, Indonesia
1 shared publication - Masfufatun Masfufatun
Universitas Wijaya Kusuma Surabaya
1 shared publication
Latest Publications
- Open Access
- 30 August 2021
- Published by Universitas Sriwijaya (Relawan) in Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya
- Vol. 8 (3) , 223-232
IMUNITAS PASIEN ASIMTOMATIS SEBAGAI SUPER-SPREADER COVID-19
Indonesia sebagai negara dengan penduduk berusia 15-44 tahun sebanyak 46,87% dari total penduduk, terdapat lonjakan kasus positif COVID-19 yang mencapai 797.723 kasus per 7 Januari 2021. Kelompok usia muda diduga menjadi kelompok penyumbang kasus infeksi tanpa gejala atau asimtomatis. Pasien asimtomatis umumnya tidak menyadari bahwa mereka berpotensi untuk menularkan infeksi dari SARS-CoV-2 penyebab COVID-19. Penulisan literatur review ini menggunakan metode pencarian literatur dari Pubmed dengan kata kunci asymptomatic, COVID-19, cytokine, inflammation. Studi ini bertujuan untuk menelaah sistem imun dari pasien asimomatis dan mengapa pasien tersebut menunjukkan gejala yang lebih ringan.
- 30 August 2021
- Published by Universitas Sriwijaya (Relawan) in Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya
- Vol. 8 (3) , 223-232
Open AccessIMUNITAS PASIEN ASIMTOMATIS SEBAGAI SUPER-SPREADER COVID-19
Indonesia sebagai negara dengan penduduk berusia 15-44 tahun sebanyak 46,87% dari total penduduk, terdapat lonjakan kasus positif COVID-19 yang mencapai 797.723 kasus per 7 Januari 2021. Kelompok usia muda diduga menjadi kelompok penyumbang kasus infeksi tanpa gejala atau asimtomatis. Pasien asimtomatis umumnya tidak menyadari bahwa mereka berpotensi untuk menularkan infeksi dari SARS-CoV-2 penyebab COVID-19. Penulisan literatur review ini menggunakan metode pencarian literatur dari Pubmed dengan kata kunci asymptomatic, COVID-19, cytokine, inflammation. Studi ini bertujuan untuk menelaah sistem imun dari pasien asimomatis dan mengapa pasien tersebut menunjukkan gejala yang lebih ringan.
- Open Access
- 23 August 2021
- Published by Veterinary World in International Journal of One Health
New phenomena for clinicians, model of Candida albicans mobilization before and after biofilm formation in the intestinal mucosa of Wistar rats (Rattus norvegicus)
Background and Aim: The virulence and antifungal resistance of Candida albicans are recently known for their ability to form biofilm. This research aimed to construct an in vivo model of C. albicans biofilm in Wistar rats' intestinal mucosa and study their mobilization while in a planktonic and biofilm formation. In this study, there was one treatment group that was treated with three antibiotics, immunosuppressants, and C. albicans. Materials and Methods: This study was divided into control and treatment groups. The data sampling was conducted after C. albicans inoculation. The C. albicans biofilm formation stage was monitored with colony-forming units method calculation every week post-inoculation and then observed by the confocal laser scanning microscope. Results: The planktonic C. albicans overgrowth occurred up to 14 days after inoculation. The formation and maturation of C. albicans biofilm in the intestinal mucosa started in the 28th and 35th-day post-inoculation, respectively. The density of planktonic C. albicans in the stool was dramatically decreased on the 35th day. Before the biofilm formation, the planktonic Candida was carried away by food scraps to be released as a stool. However, there were minuscule or no planktonic Candida observed in the stool during and after biofilm formation. Instead, they were attached to the caecum's mucosa as a biofilm. Conclusion: We have proved that the planktonic C. albicans with its mobile nature were carried into the stool along with the rest of the feed, as we observed a lot of C. albicans cells found in the stool. Meanwhile, on day 28 after administration of antibiotics and immunosuppressants, no C. albicans was found in the stool samples, and at the same time, we observed C. albicans cells and their matrix attached to the intestinal mucosa as a biofilm.
- 23 August 2021
- Published by Veterinary World in International Journal of One Health
Open AccessNew phenomena for clinicians, model of Candida albicans mobilization before and after biofilm formation in the intestinal mucosa of Wistar rats (Rattus norvegicus)
Background and Aim: The virulence and antifungal resistance of Candida albicans are recently known for their ability to form biofilm. This research aimed to construct an in vivo model of C. albicans biofilm in Wistar rats' intestinal mucosa and study their mobilization while in a planktonic and biofilm formation. In this study, there was one treatment group that was treated with three antibiotics, immunosuppressants, and C. albicans. Materials and Methods: This study was divided into control and treatment groups. The data sampling was conducted after C. albicans inoculation. The C. albicans biofilm formation stage was monitored with colony-forming units method calculation every week post-inoculation and then observed by the confocal laser scanning microscope. Results: The planktonic C. albicans overgrowth occurred up to 14 days after inoculation. The formation and maturation of C. albicans biofilm in the intestinal mucosa started in the 28th and 35th-day post-inoculation, respectively. The density of planktonic C. albicans in the stool was dramatically decreased on the 35th day. Before the biofilm formation, the planktonic Candida was carried away by food scraps to be released as a stool. However, there were minuscule or no planktonic Candida observed in the stool during and after biofilm formation. Instead, they were attached to the caecum's mucosa as a biofilm. Conclusion: We have proved that the planktonic C. albicans with its mobile nature were carried into the stool along with the rest of the feed, as we observed a lot of C. albicans cells found in the stool. Meanwhile, on day 28 after administration of antibiotics and immunosuppressants, no C. albicans was found in the stool samples, and at the same time, we observed C. albicans cells and their matrix attached to the intestinal mucosa as a biofilm.
- Open Access
- 13 April 2020
- Published by Universitas Wijaya Kusuma Surabaya in Jurnal Ilmiah Kedokteran Wijaya Kusuma
- Vol. 9 (1) , 60-76
Mekanisme Escape dan Respon Imun innate terhadap Candida albicans
Candidiasis is an infection caused by fungal Candida albicans. The incidence of candidiasis is pretty high in Indonesia. Candida albicans develop their pathogenicity by several ways so that it can invade and escape from the immune system. The host’s immune system must always be vigilant to recognized antigen through various receptors, activation of the transduction pathway and activation of various immune cells. But as organisms that struggle to survive, Candida also develops mechanisms to escape the immune response. There are so many articles have written the immune response against candidiasis, this review aims to understand more and updating information about the biological processes of pathogenicity of fungi and the mechanism of Candida albicans in escaping immune responses, the role of each innate molecule and immune cell, and clinical aspect to Candida albicans infections. We already facing the big challenges against therapy of fungal infection, so by understanding the escape mechanism of Candida albicans, it is possible to developed antifungal or Candida vaccine in the future, therefore the incidence of candidiasis can be suppressed.
- 13 April 2020
- Published by Universitas Wijaya Kusuma Surabaya in Jurnal Ilmiah Kedokteran Wijaya Kusuma
- Vol. 9 (1) , 60-76
Open AccessMekanisme Escape dan Respon Imun innate terhadap Candida albicans
Candidiasis is an infection caused by fungal Candida albicans. The incidence of candidiasis is pretty high in Indonesia. Candida albicans develop their pathogenicity by several ways so that it can invade and escape from the immune system. The host’s immune system must always be vigilant to recognized antigen through various receptors, activation of the transduction pathway and activation of various immune cells. But as organisms that struggle to survive, Candida also develops mechanisms to escape the immune response. There are so many articles have written the immune response against candidiasis, this review aims to understand more and updating information about the biological processes of pathogenicity of fungi and the mechanism of Candida albicans in escaping immune responses, the role of each innate molecule and immune cell, and clinical aspect to Candida albicans infections. We already facing the big challenges against therapy of fungal infection, so by understanding the escape mechanism of Candida albicans, it is possible to developed antifungal or Candida vaccine in the future, therefore the incidence of candidiasis can be suppressed.
- Open Access
- 12 June 2017
- Published by Universitas Wijaya Kusuma Surabaya in Jurnal Ilmiah Kedokteran Wijaya Kusuma
- Vol. 3 (1) , 40
Interleukin-6 (IL-6) Level as an Indikator of Progresivity Rheumatoid Arthritis (RA) Disease
Rheumatoid Arthritis (RA) is autoimmune disease that attacks joints and synovial tissues. Rheumatoid Arthritis is characterized by inflammation that involves production of cytokines such as Interleukin 6 (IL-6). Increasing of interleukin 6 has correlation with activity and progressivity of the disease. This research was designed to know whether IL- 6 could be used as indicator progressivity of RA. The method that used for measuring IL-6 level is ELISA (Enzyme Linked Immunosorbent Assay), using the principle antigen-antibody binding. In early stage there were 9 persons (S01, S02, S03, S04, S07, S08, S09, S10 and S14) with of IL-6 level (mean : 3.640 pg/mL), intermediate stage there were 3 persons (S06, S13 and S15) with IL-6 level (mean : 12.453 pg/mL), late stage : 3 persons (S05, S11 and S12) with IL-6 level (mean : 59.349 pg/mL).
- 12 June 2017
- Published by Universitas Wijaya Kusuma Surabaya in Jurnal Ilmiah Kedokteran Wijaya Kusuma
- Vol. 3 (1) , 40
Open AccessInterleukin-6 (IL-6) Level as an Indikator of Progresivity Rheumatoid Arthritis (RA) Disease
Rheumatoid Arthritis (RA) is autoimmune disease that attacks joints and synovial tissues. Rheumatoid Arthritis is characterized by inflammation that involves production of cytokines such as Interleukin 6 (IL-6). Increasing of interleukin 6 has correlation with activity and progressivity of the disease. This research was designed to know whether IL- 6 could be used as indicator progressivity of RA. The method that used for measuring IL-6 level is ELISA (Enzyme Linked Immunosorbent Assay), using the principle antigen-antibody binding. In early stage there were 9 persons (S01, S02, S03, S04, S07, S08, S09, S10 and S14) with of IL-6 level (mean : 3.640 pg/mL), intermediate stage there were 3 persons (S06, S13 and S15) with IL-6 level (mean : 12.453 pg/mL), late stage : 3 persons (S05, S11 and S12) with IL-6 level (mean : 59.349 pg/mL).